Polymorphs of a mGluR5 receptor antagonist

Details for Australian Patent Application No. 2007336369 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Kuang, Shan-Ming; Meier, Roland; Yang, Jason; Miller, Doreen; Glomme, Alexander; Moog, Regina; Grassmann, Olaf; Cleary, Thomas P.; Rohrer, Franziska E.

Agent Spruson & Ferguson

Pub. Number AU-A-2007336369

PCT Pub. Number WO2008/074697

Priority 60/876,398 21.12.06 US

Filing date 11 December 2007

Wipo publication date 26 June 2008

International Classifications

C07D 401/06 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/4439 (2006.01)

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

9 July 2009 PCT application entered the National Phase

  PCT publication WO2008/074697 Priority application(s): WO2008/074697

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007336372-Optical transmission element having high temperature stability

2007336365-Process for preparing 3,5-di-Omicron-acyl-2-fluoro-2-C-methyl -D-ribono-gamma-lactone